Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug 10;18(8):1739.
doi: 10.3390/ijms18081739.

Speechlessness in Gilles De La Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

Affiliations
Free PMC article
Case Reports

Speechlessness in Gilles De La Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

Ewgeni Jakubovski et al. Int J Mol Sci. .
Free PMC article

Abstract

We report the cases of two young German male patients with treatment-resistant Tourette syndrome (TS), who suffer from incapacitating stuttering-like speech disfluencies caused by vocal blocking tics and palilalia. Case 1: a 19-year old patient received medical cannabis at a dose of 1 × 0.1 g cannabis daily. Case 2: a 16-year old patient initially received dronabinol at a maximum dose of 22.4-33.6 mg daily. Both treatments provided significant symptom improvement of vocal blocking tics as well as of comorbid conditions and were well tolerated. Thus, cannabis-based medicine appears to be effective in treatment-resistant TS patients with vocal blocking tics.

Keywords: Tourette syndrome; blocking tics; cannabis; dysfluency; nabiximols; tics.

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by 3 articles

References

    1. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J. Psychosom. Res. 2009;67:475–483. doi: 10.1016/j.jpsychores.2009.07.010. - DOI - PubMed
    1. Knight T., Steeves T., Day L., Lowerison M., Jette N., Pringsheim T. Prevalence of tic disorders: A systematic review and meta-analysis. Pediatr. Neurol. 2012;47:77–90. doi: 10.1016/j.pediatrneurol.2012.05.002. - DOI - PubMed
    1. Sambrani T., Jakubovski E., Müller-Vahl K.R. New insights into clinical characteristics of Gilles de la Tourette syndrome: Findings in 1032 patients from a single German center. Front. Neurosci. 2016 doi: 10.3389/fnins.2016.00415. - DOI - PMC - PubMed
    1. Ganos C., Müller-Vahl K., Bhatia K.P. Blocking phenomena in Gilles de la Tourette syndrome. Mov. Disord. Clin. Pract. 2015;2:438–439. doi: 10.1002/mdc3.12199. - DOI
    1. Abwender D.A., Trinidad K.S., Jones K.R., Como P.G., Hymes E., Kurlan R. Features resembling Tourette’s syndrome in developmental stutterers. Brain Lang. 1998;62:455–464. doi: 10.1006/brln.1998.1948. - DOI - PubMed

Publication types

Feedback